MARKETS

FDA grants Medivir ´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease

Kgaogelo MatshwiKgaogelo Matshwi
Apr 25, 2024 - 09:50
 0  5
FDA grants Medivir ´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease
Read More

Tags:

Previous Article

China's largest auto show showcases all-electric future, local brands dominate

Next Article

Toyota Exhibiting at Beijing Motor Show 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Kgaogelo Matshwi
Kgaogelo Matshwi

Related Posts

Stocks Finish Week Strong | Beyond the Bell

Stocks Finish Week Strong | Beyond the Bell

Kgaogelo Matshwi May 3, 2024  0  0

Wall Street steered billions to blacklisted Chinese companies: probe, WSJ reports

Wall Street steered billions to blacklisted Chinese com...

Kgaogelo Matshwi Apr 18, 2024  0  2

More than Half of Global Organizations Plan to Increase Their Investment in Human-Centered Software Design in the Next Year, According to Progress Sponsored Research Study

More than Half of Global Organizations Plan to Increase...

Kgaogelo Matshwi Apr 9, 2024  0  5